These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Cytomegalic ulcer in the caecum after renal transplantation (author's transl)]. Clavadetscher P; Sulser H; Linder E; Deyhle P Dtsch Med Wochenschr; 1974 Oct; 99(40):1970-2. PubMed ID: 4369529 [No Abstract] [Full Text] [Related]
3. Congenital cytomegalovirus infection after recurrent infection in a mother with a renal transplant. Blau EB; Gross JR Pediatr Nephrol; 1997 Jun; 11(3):361-2. PubMed ID: 9203194 [TBL] [Abstract][Full Text] [Related]
4. [Case of probable central nervous system cytomegaly developing in the course of long-term immunosuppressive treatment]. Marks E; Zuzewicz W; Wolska E Wiad Lek; 1975 Aug; 28(15):1325-8. PubMed ID: 169637 [No Abstract] [Full Text] [Related]
5. Strategy of cytomegalovirus infection prevention in renal transplantation. Legendre C; Rouzioux C; Ducloux D; Delamarre C; Chkoff N; Thervet E; Page B; Kreis H Adv Nephrol Necker Hosp; 1994; 23():331-45. PubMed ID: 8154363 [No Abstract] [Full Text] [Related]
8. Primary cytomegalovirus infection and hepatitis in a renal allograft recipient. Foster KM; Ralston M; Field PR; Hayes JM; Lord RS Aust N Z J Med; 1972 May; 2(2):148-52. PubMed ID: 4342441 [No Abstract] [Full Text] [Related]
11. Cytomegalovirus syndrome post-renal transplantation. Treatment with cytosine arabinoside. Fine RN; Malekzadeh M; Grushkin CM; Wright HT Calif Med; 1973 Mar; 118(3):46-9. PubMed ID: 4347632 [No Abstract] [Full Text] [Related]
12. Cytomegalovirus and Clostridium difficile ischemic colitis in a renal transplant recipient: a lethal complication of anti-rejection therapy? Veroux M; Puzzo L; Corona D; Buffone A; Tallarita T; Murabito P; Veroux P Urol Int; 2007; 79(2):177-9; discussion 180. PubMed ID: 17851290 [TBL] [Abstract][Full Text] [Related]
13. Unusual presentation of cytomegalovirus infection in patients after organ transplant. Tiple A; Kamar N; Esposito L; Mengelle C; Combelles S; Otal P; Celine Guilbeau-Frugier C; Rostaing L Exp Clin Transplant; 2009 Mar; 7(1):45-9. PubMed ID: 19364312 [TBL] [Abstract][Full Text] [Related]
14. Iatrogenic modification of tissue responses to infectious agents in the central nervous system. Bailey OT; Wolf A; Schneck SA; Rorke LB Res Publ Assoc Res Nerv Ment Dis; 1968; 44():445-62. PubMed ID: 4307813 [No Abstract] [Full Text] [Related]
15. Risk factors in the development of cytomegalovirus-related pneumonia in renal transplant recipients. Peterson PK; Balfour HH; Fryd DS; Ferguson R; Kronenberg R; Simmons RL J Infect Dis; 1983 Dec; 148(6):1121. PubMed ID: 6317769 [No Abstract] [Full Text] [Related]
16. CMV management in a post-kidney-transplant child. Elshihabi I Transplant Proc; 1994 Feb; 26(1):131. PubMed ID: 8108907 [No Abstract] [Full Text] [Related]
18. CMV infection in post kidney transplant recipient. Abdelrahman M; Karkar A Saudi J Kidney Dis Transpl; 2009 May; 20(3):481-2. PubMed ID: 19414958 [No Abstract] [Full Text] [Related]
19. Reversible acute renal failure caused by the combined use of foscarnet and cyclosporin in organ transplanted patients. Morales JM; Muñoz MA; Fernández Zataraín G; García Cantón C; García Rubiales MA; Andrés A; Aguado JM; Gonzalez Pinto I Nephrol Dial Transplant; 1995; 10(6):882-3. PubMed ID: 7566623 [No Abstract] [Full Text] [Related]
20. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients. Kamar N; Mengelle C; Esposito L; Guitard J; Mehrenberger M; Lavayssière L; Ribes D; Cointault O; Durand D; Izopet J; Rostaing L J Med Virol; 2008 Jun; 80(6):1012-7. PubMed ID: 18428146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]